MEDALLION FINANCIAL CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MEDALLION FINANCIAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.04M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $35.88M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $55.08M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $43.84M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $54.11M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | ($34.78M) | Mar 10, 2023 |
| FY2019 | Dec 31, 2019 | ($465.0K) | Mar 30, 2020 |
| FY2019 | Sep 30, 2019 | $4.98M | Mar 30, 2020 |
| FY2019 | Jun 30, 2019 | ($7.50M) | Mar 30, 2020 |
| FY2019 | Mar 31, 2019 | $1.23M | Mar 30, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $126.28M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $108.68M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $113.78M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $108.74M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $78.73M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $78.71M | Mar 10, 2023 |
| FY2021 | Dec 31, 2019 | $64.94M | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | $66.55M | Mar 16, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.96B | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $2.87B | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $2.59B | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $2.26B | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $1.87B | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $1.64B | Mar 10, 2023 |
| FY2021 | Dec 31, 2019 | $1.54B | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | $1.38B | Mar 16, 2021 |
| FY2018 | Dec 31, 2017 | $1.08B | Mar 13, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.45B | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $2.43B | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $2.18B | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.89B | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $1.52B | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $1.34B | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.21B | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $1.09B | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $913.13M | Mar 13, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $408.62M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $370.17M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $342.99M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $301.74M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $287.04M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $231.41M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $263.15M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $262.61M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $164.23M | Mar 13, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $150.80M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $150.80M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $150.80M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $150.80M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $150.80M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $150.80M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $150.80M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $150.80M | Mar 30, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $162.37M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $130.26M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $103.88M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $66.67M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $30.61M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | ($23.50M) | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $11.28M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $13.04M | Mar 30, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $136.27M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $98.24M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $52.59M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $33.17M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $64.48M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $54.74M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $17.70M | Mar 16, 2021 |
| FY2018 | Dec 31, 2018 | $57.71M | Mar 13, 2019 |
| FY2018 | Dec 31, 2017 | $42.51M | Mar 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.99M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $232.16M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $235.54M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $214.32M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $219.97M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $153.72M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $174.61M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $158.81M | Mar 30, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Mar 10, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 30, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 30, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 30, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 30, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Mar 10, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 30, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 30, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 30, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 30, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 23.31M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 23.14M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | 23.45M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | 23.06M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 25.17M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | 24.88M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | 24.65M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | 24.43M | Mar 30, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.97M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $9.39M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $7.70M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $7.54M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $0 | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $0 | Mar 10, 2023 |